Minovia Therapeutics Ltd.

This early-stage trial tests a new treatment called MNV-201 for people with low-risk myelodysplastic syndrome (MDS), a bone marrow disorder that causes low blood counts. The therapy uses the patient's own blood stem cells enriched with mitochondria from donated placenta tissue. T…

This study collects blood and skin samples from 100 people with primary mitochondrial diseases and healthy volunteers. Researchers will study how different mitochondrial mutations affect cell function, aiming to develop new treatments. No direct treatment is given; participation …